LINICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 396 JPY | -2.94% |
|
+1.54% | -25.28% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
Calendar
2024-05-14
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
396
JPY
Average target price
500
JPY
Spread / Average Target
+26.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.28% | 56.82M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 2183 Stock
- News Linical Co., Ltd.
- Linical Cuts Revenue, Earnings Forecast on Lower-Than-Expected Sales, Extraordinary Losses
